Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Revance Therapeutics, Inc. | Director | Common Stock | 51.5K | $196K | $3.80 | May 1, 2024 | Direct |
TherapeuticsMD, Inc. | Director | Restricted Stock Units | 5K | $18.2K | $3.64 | Sep 29, 2022 | Direct |
Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75K | Jul 1, 2024 | Direct | ||
Structure Therapeutics Inc. | Director | Share option (right to buy) | 75K | Aug 26, 2024 | Direct | ||
Revance Therapeutics, Inc. | Director | Stock Option (Right to buy) | 23.5K | May 1, 2024 | Direct |